What are the benefits and harms of enteral tube feeding for people with severe dementia?

2021 ◽  
Author(s):  
Agustín Ciapponi ◽  
Sera Tort
2021 ◽  
Vol 2021 (8) ◽  
Author(s):  
Nathan Davies ◽  
Yolanda Barrado-Martín ◽  
Victoria Vickerstaff ◽  
Greta Rait ◽  
Akiko Fukui ◽  
...  

Author(s):  
Nathan Davies ◽  
Yolanda Barrado-Martin ◽  
Greta Rait ◽  
Akiko Fukui ◽  
Bridget Candy ◽  
...  

2014 ◽  
Vol 44 (12a) ◽  
pp. 1199-1204 ◽  
Author(s):  
J. J. Arevalo-Manso ◽  
P. Martinez-Sanchez ◽  
B. Juarez-Martin ◽  
B. Fuentes ◽  
G. Ruiz-Ares ◽  
...  

1999 ◽  
Vol 6 (3) ◽  
pp. 70
Author(s):  
N. Owens ◽  
M. Sullins ◽  
B. Blandford ◽  
H. Snider

2017 ◽  
Vol 117 (11) ◽  
pp. 1808-1815 ◽  
Author(s):  
Francis M. Hollander ◽  
Nicole M. de Roos ◽  
Gerdien Belle van Meerkerk ◽  
Ferdinand Teding van Berkhout ◽  
Harry G.M. Heijerman ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Takahisa Mori ◽  
Kazuhiro Yoshioka

Abstract Background Malnutrition often occurs in acute stroke patients receiving enteral tube feeding (ETF). Unless malnutrition is improved, their clinical outcome is poor. However, strategies to improve malnutrition in these patients have not been established. Branched-chain amino acids (BCAA) may enhance protein synthesis and attenuate inflammation. Our study aimed to investigate whether a leucine enriched BCAA dietary supplement (LEBDs) could quickly increase serum levels of albumin (Alb) or transthyretin (TTR) and decrease high-sensitivity C-reactive protein (CRP) in the development of severe malnutrition within a few days after stroke onset compared to standard BCAA dietary supplement (SBDs). Methods We retrospectively included acute stroke patients who: 1) were admitted between August 2016 and July 2017; 2) underwent ETF for 7 days or longer after admission, and 3) underwent blood examination of Alb, TTR, and CRP on admission, the fifth day and the seventh day. We defined severe malnutrition as severe hypoproteinemia: decrease of TTR to less than 15 mg/dl on the 5th day. In LEBDs and SBDs groups, patients started to receive a dietary supplement containing leucine of 1.44 and 0. 72 g twice a day on the fifth day, respectively. We evaluated Alb (g/dl), TTR (mg/dl), and CRP (mg/dl) on admission, the fifth day, and the seventh day. Results Twenty-nine patients met our inclusion criteria:15 in LEBDs and 14 in SBDs. In LEBDs and SBDs groups, the median Alb was 3.5 and 3.3 g/dl, TTR was 12.7 and 10.7 mg/dl, and CRP was 1.02 and 0.673 mg/dl on admission, respectively. In LEBDs, the median Alb and TTR decreased to 2.6 g/dl and 11.9 mg/dl, and CRP increased to 5.337 mg/dl on the fifth day. On the 7th day, TTR increased, and CRP decreased, although Alb did not improve. In SBDs, the median Alb and TTR decreased to 2.6 g/dl and 9.7 mg/dl, and CRP increased to 4.077 mg/dl on the fifth day. On the 7th day, Alb, TTR, and CRP did not improve. Conclusion In acute stroke patients receiving leucine enriched BCAA dietary supplement, quick improvements in transthyretin and CRP were observed.


Sign in / Sign up

Export Citation Format

Share Document